Home  >  News
Eppen_Cent_Feb24
you can get e-magazine links on WhatsApp. Click here
Corporate + Font Resize -

Dr Reddy’s gets VAI status from US FDA for its two facilities

Our Bureau, Bengaluru
Monday, February 12, 2024, 17:20 Hrs  [IST]

Dr Reddy’s R&D centre which is the Integrated Product Development Organisation (IPDO) located at Bachupally, Hyderabad, underwent a GMP and Pre-Approval Inspection (PAI) by the US FDA in December 2023. The US FDA has now classified that inspection too as Voluntary Action Indicated (VAI).
 
This is the second piece of good news in recent days. On February 10, the company stated that it had updated that the US FDA had issued VAI status to FTO-3, our largest formulations manufacturing plant also in Bachupally and concluded the inspection as closed, stated the Hyderabad-based pharma major.

 




*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
CEI_CPT_CLI_150x60
Pharma_India_Expo24
India Lab Expo
Copyright © 2023 Saffron Media Pvt. Ltd |